US Commercial Property Price Growth Eases From Record High

Quick take
2 min read
April 21, 2022
The headline rate of U.S. commercial real estate price growth eased from all-time highs in March. The RCA CPPI National All-Property Index increased 17.4% from a year ago, down from the record 19.3% rate seen at the start of 2022, the latest RCA CPPI: US report shows. The index slipped 0.4% in March from February. Retail price growth decelerated in March. The index rose 16.3% from a year earlier, a slowing from the pace seen in recent months. The index dropped 0.7% in March from February, the first month-over-month drop for retail since 2020.
charts showing RCA CPPI price trends across sectors through March 2022
Apartment prices posted a 22.4% increase in March from a year prior, close to the annual growth rates seen earlier in 2022. The apartment index rose 1.1% from February, the second highest monthly rate for a property sector behind the industrial series. The industrial index jumped 30.1% from a year ago, extending its record pace of price growth. Suburban office properties posted a 9.3% year-over-year increase in March. CBD office prices, which had been falling much of 2021, rose 7.5% year-over-year. The spread between suburban office and CBD office growth has narrowed since its peak in Q3 2021, as suburban office price increases have weakened and CBD prices have strengthened.

Subscribe today
to have insights delivered to your inbox.

Research and Insights

Our investing insights explore the topics that matter most, whether on climate and ESG, current market trends or global investing and risk management across asset classes.

The content of this page is for informational purposes only and is intended for institutional professionals with the analytical resources and tools necessary to interpret any performance information. Nothing herein is intended to recommend any product, tool or service. For all references to laws, rules or regulations, please note that the information is provided “as is” and does not constitute legal advice or any binding interpretation. Any approach to comply with regulatory or policy initiatives should be discussed with your own legal counsel and/or the relevant competent authority, as needed.